Date | Insider | Price | Amount |
---|---|---|---|
7-6-2020 Insider Buy |
John M. Dineen Director |
$59.11 CAGR » |
$513,725.01 8,691 shares |
3-20-2020 Insider Buy |
Jason M. Meggs Chief Financial Officer |
$36.74 CAGR » |
$130,612.50 3,555 shares |
3-19-2020 Insider Buy |
Paul Colvin Pres., Clinical Solutions |
$36.65 CAGR » |
$47,645.00 1,300 shares |
12-17-2018 Insider Buy |
Jason M. Meggs Chief Financial Officer |
$41.25 CAGR » |
$150,562.50 3,650 shares |
12-17-2018 Insider Buy |
Jonathan Olefson General Counsel & Corp Secty |
$41.27 CAGR » |
$30,954.75 750 shares |
Also See: Institutional Holders of SYNH
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/07/2020 | |
End date: | 09/28/2023 | |
Start price/share: | $57.40 | |
End price/share: | $42.98 | |
Dividends collected/share: | $0.00 | |
Total return: | -25.12% | |
Average Annual Total Return: | -8.57% | |
Starting investment: | $10,000.00 | |
Ending investment: | $7,488.90 | |
Years: | 3.23 |
SYNH Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent SYNH insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding SYNH
Free SYNH Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |